B

Bandhan BSE Healthcare Index Fund Direct Plan - Growth

Bandhan AMC Limited

NAV

₹12.2106

NAV as of 13 Nov 2026

-0.0301 (-0.2459%)
Returns, 3Y

—

Annualised return

AUM (FUND SIZE)

₹24 Cr

Assets Under Mgmt

SINCE INCEPTION

+9.76%

Launched 09 Sep 2024

₹1 SINCE LAUNCH

₹1.23

Indexed wealth

MAX DRAWDOWN

-16.18%

Historical peak to trough

RECOVERY TIME

5 mo

To previous peak

CONSISTENCY

1 positive yrs

1 negative yrs

Category

IndexVery High Risk

Fund Info

INF194KB1IS2Bandhan AMC Limited
+18.87%1Y Absolute Return
-0.25%1D
Loading NAV history…

Past performance is not an indicator of future returns.

Returns calculator comparison

Compare an illustrative investment outcome across return assumptions.

AssetProjected corpusTotal investedGainAnnual return
Bandhan BSE Healthcare Index Fund Direct Plan - GrowthFund 1Y annualised return · 5Y history unavailable
₹11,80,053
₹7,32,612₹4,47,441+18.87%
EPFIllustrative annual assumption
₹8,95,132
₹7,32,612₹1,62,520+8.25%
Residential propertyIllustrative annual assumption
₹8,67,662
₹7,32,612₹1,35,050+7.00%
PPFIllustrative annual assumption
₹8,69,819
₹7,32,612₹1,37,207+7.10%
Bank fixed depositIllustrative annual assumption
₹8,56,981
₹7,32,612₹1,24,369+6.50%
GoldIllustrative annual assumption
₹8,67,662
₹7,32,612₹1,35,050+7.00%
Savings accountIllustrative annual assumption
₹7,86,827
₹7,32,612₹54,215+3.00%

Illustration only. Fund results use the available NAV-derived annualised return and can be negative. Reference rows are assumptions, not current quoted rates or guaranteed returns; property excludes transaction costs, taxes, and liquidity constraints. Mutual fund investments are subject to market risk.

Wealth multiple

₹1 became₹1.10
₹1 Lakh since launch₹1.10 Lakh
Fund age2.2 yrs

Fund information

Scheme code152844
ISININF194KB1IS2
BenchmarkBSE Healthcare TRI
CategoryOther Scheme - Index Funds
Expense ratio0.36%
Exit loadExit load of 0.25%, if redeemed within 15 days.
Minimum SIP₹100 SIP

Return comparison

25th / 1122 in category
PeriodFundBenchmarkCategory avg
1M+200.04%——
3M+15.65%——
6M+26.06%——
1Y+18.87%—+1.74%
Since Launch+9.76%——

Risk-adjusted performance

Every measure is expanded with a plain-language reading of the latest calculated value.

Sharpe ratio

0.27

Return earned for the risk taken.

Moderate

Moderate risk-adjusted returns. The reward for risk has been average.

Sortino ratio

0.38

Return earned while limiting downside risk.

Moderate

Moderate downside risk-adjusted performance.

Standard deviation

13.75%

How much the fund’s returns fluctuate over time.

Moderate volatility

Returns can move up and down noticeably.

Beta

—

How closely the fund moves with the market.

Unavailable

This measure needs sufficient fund and benchmark history to calculate.

Alpha

—

Extra return generated above the benchmark.

Unavailable

This measure needs sufficient fund and benchmark history to calculate.

Treynor ratio

—

Return earned for each unit of market risk taken.

Unavailable

This measure needs sufficient fund and benchmark history to calculate.

Calmar ratio

0.60

How well the fund rewarded investors relative to its biggest decline.

Good

Good return relative to the drawdowns experienced.

Information ratio

—

How consistently the fund outperformed its benchmark.

Unavailable

This measure needs sufficient fund and benchmark history to calculate.

Portfolio allocation

Latest disclosed portfolio mix

Asset allocation

Allocation data has not been disclosed.

Market cap allocation

Small Cap
41.25%
Large Cap
29.76%
Mid Cap
26.58%
Unclassified
2.34%

Sector allocation

Equity exposure by sector

Healthcare
99.74%
Materials
0.19%

Top holdings

10 of 128 disclosed positions

HoldingSectorInstrument typeWeight
Sun Pharmaceutical Industries LtdHealthcareEquity13.35%
Divi's Laboratories LtdHealthcareEquity6.38%
Apollo Hospitals Enterprise LtdHealthcareEquity5.68%
Cipla LtdHealthcareEquity5.18%
Max Healthcare Institute LtdHealthcareEquity5.05%
Torrent Pharmaceuticals LtdHealthcareEquity4.53%
Dr. Reddy's Laboratories LtdHealthcareEquity4.35%
Laurus Labs LtdHealthcareEquity4.33%
Lupin LtdHealthcareEquity3.64%
Fortis Healthcare LtdHealthcareEquity3.06%

Fund management

AB
Abhishek Jain

Since 2025 · Prior to joining Bandhan MF he was associated with Groww MF, Edelweiss Tokio Life Insurance, Acko General Insurance and Shriram Asset Management Co Ltd.

Mr. Jain has done BA, CA

MA
Mayuresh Nagvekar

Since 2026 · Prior to joining the Bandhan AMC, he was associated with Colour Arts,

B.Com in Financial Management

Compare similar funds

No comparable category funds are available yet.
Summary

A very high-risk other scheme - index funds fund. Losses and swings stayed contained — worst fall -16.2%, volatility 13.8%. Healthcare makes up 100% — trouble in that sector hits the whole fund.

Strengths
  • Losses and swings stayed contained — worst fall -16.2%, volatility 13.8%.
  • Recovered from its worst fall in 5 months.
  • Ranks 25 of 1122 in its category over 1 year.
Weaknesses
  • None
Ideal investor
  • Needs a 5+ years horizon to ride out its very high risk level.
  • Good fit for SIPs — spreading purchases smooths out 13.8% volatility.
Risk drivers
  • Healthcare makes up 100% — trouble in that sector hits the whole fund.